AbbVie Inc. stock outperforms competitors despite losses on the day
AbbVie Inc. closed 15.68% short of its 52-week high of $207.32, which the company achieved on October 31st.
Neutral Rating for AbbVie Amid Revenue Challenges and Limited Upside Potential
AbbVie (ABBV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tim Anderson from Bank of ...
AbbVie price target lowered to $205 from $215 at Citi
Citi lowered the firm’s price target on AbbVie (ABBV) to $205 from $215 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the ...
AbbVie Inc. stock underperforms Monday when compared to competitors despite daily gains
AbbVie Inc. closed 14.67% below its 52-week high of $207.32, which the company achieved on October 31st.